GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Oncology Network Inc (NAS:AONCW) » Definitions » Total Liabilities

American Oncology Network (American Oncology Network) Total Liabilities : $365.81 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is American Oncology Network Total Liabilities?

American Oncology Network's Total Liabilities for the quarter that ended in Mar. 2024 was $365.81 Mil.

American Oncology Network's quarterly Total Liabilities increased from Sep. 2023 ($300.92 Mil) to Dec. 2023 ($303.74 Mil) and increased from Dec. 2023 ($303.74 Mil) to Mar. 2024 ($365.81 Mil).

American Oncology Network's annual Total Liabilities increased from Dec. 2021 ($188.75 Mil) to Dec. 2022 ($264.21 Mil) and increased from Dec. 2022 ($264.21 Mil) to Dec. 2023 ($303.74 Mil).


American Oncology Network Total Liabilities Historical Data

The historical data trend for American Oncology Network's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oncology Network Total Liabilities Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Liabilities
- 188.75 264.21 303.74

American Oncology Network Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial 264.21 - 300.92 303.74 365.81

American Oncology Network Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

American Oncology Network's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=169.045+(120.444+14.251
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=303.74

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=374.453-70.713
=303.74

American Oncology Network's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=233.829+(120.642+11.342
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=365.81

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=421.921-56.108
=365.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Oncology Network Total Liabilities Related Terms

Thank you for viewing the detailed overview of American Oncology Network's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


American Oncology Network (American Oncology Network) Business Description

Traded in Other Exchanges
Address
10485 NE 6th Street, Unit 3930, Bellevue, WA, USA, 98004
American Oncology Network Inc Formerly American Oncology Network LLC is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services through 24 oncology practices located in Arkansas, Louisiana, Indiana, Virginia, Ohio, Nevada, Iowa, Missouri, Washington, North Carolina, Michigan, Maryland, South Carolina, Arizona, and Georgia. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services.